Scientists have discovered a potential new way to treat one of the most aggressive blood cancers, offering hope to thousands ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

It is an aggressive cancer that affects the blood and bone marrow and is very hard to treat. Even with improvements in care, ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

People at high risk of acute myeloid leukaemia (AML) can be identified years in advance, but there is currently no treatment ...

Though AML is a genetically heterogeneous disease ... and the University of Helsinki -- report in the current issue of Nature a potentially new combination therapy that, in preclinical studies ...

Cryptocurrencies, with their pseudonymous nature, can make this easier, but regulations are in place to fight back. Implementing robust AML measures helps ensure the integrity of financial systems ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...